Lyn is frequently overexpressed in numerous tumor types, including chronic myelogenous leukemia, renal cancer, cervical cancer, head and neck squamous cell carcinoma, gastric cancer, and prostate cancer [38]. This evidence concerns the gene LYN and chronic myelogenous leukemia, BCR-ABL1 positive.